KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Cash from Investing Activities (2016 - 2026)

Biomarin Pharmaceutical's Cash from Investing Activities history spans 17 years, with the latest figure at -$42.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 155.56% year-over-year to -$42.4 million, compared with a TTM value of -$414.2 million through Dec 2025, down 403.49%, and an annual FY2025 reading of -$414.2 million, down 403.49% over the prior year.
  • Cash from Investing Activities for Q4 2025 was -$42.4 million at Biomarin Pharmaceutical, up from -$331.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $90.5 million in Q2 2024, with the low at -$331.0 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is -$38.8 million, with a median of -$29.9 million recorded in 2022.
  • Year-over-year, Cash from Investing Activities skyrocketed 224.01% in 2022 and then plummeted 1948.42% in 2025.
  • Tracing BMRN's Cash from Investing Activities over 5 years: stood at -$55.4 million in 2021, then grew by 1.28% to -$54.7 million in 2022, then fell by 18.74% to -$65.0 million in 2023, then skyrocketed by 217.61% to $76.4 million in 2024, then tumbled by 155.56% to -$42.4 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Cash from Investing Activities are -$42.4 million (Q4 2025), -$331.0 million (Q3 2025), and -$12.6 million (Q2 2025).